During the past decade, Michiana Hematology Oncology PC-Westville conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 66 clinical trials were completed, i.e. on average, 440% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 35 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michiana Hematology Oncology PC-Westville" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "Gynecologic Oncology Group" with 13 trials sponsored, "SWOG Cancer Research Network" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "GOG Foundation" with 9 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michiana Hematology Oncology PC-Westville" #1 collaborator was "National Cancer Institute (NCI)" with 40 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Michiana Hematology Oncology PC-Westville" are "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (8 trials), "Stage IV Ovarian Cancer AJCC v6 and v7" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IIA Fallopian Tube Cancer AJCC v6 and v7" (7 trials) and "Stage IIB Fallopian Tube Cancer AJCC v6 and v7" (7 trials). Many other conditions were trialed in "Michiana Hematology Oncology PC-Westville" in a lesser frequency.

Most popular intervention types in "Michiana Hematology Oncology PC-Westville" are "Drug" (78 trials), "Other" (78 trials), "Biological" (39 trials), "Procedure" (15 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (30 trials), "Paclitaxel" (23 trials), "Bevacizumab" (20 trials) and "Carboplatin" (19 trials). Other intervention names were less common.

The vast majority of trials in "Michiana Hematology Oncology PC-Westville" are 54 trials for "All" genders, 35 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Michiana Hematology Oncology PC-Westville". undefined are not yet recruiting, 3 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Michiana Hematology Oncology PC-Westville, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Michiana Hematology Oncology PC-Westville, 4 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".